Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3699387017 | Fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3700160017 | Fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5074223016 | Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3699386014 | Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized conventional release suspension for inhalation | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3699387017 | Fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3699388010 | Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized conventional release suspension for inhalation (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3700160017 | Fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3759884011 | Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation pressurized conventional release suspension for inhalation (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5074223016 | Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | Is a | Fluticasone- and salmeterol-containing product | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | Has precise active ingredient | Fluticasone propionate | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | Has presentation strength denominator unit (attribute) | Actuation (unit of presentation) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | Has basis of strength substance (attribute) | Fluticasone propionate | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | Has basis of strength substance (attribute) | Salmeterol (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | Has presentation strength numerator value | 50 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | Has presentation strength numerator unit (attribute) | mcg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | Has unit of presentation | Actuation (unit of presentation) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | Has presentation strength numerator unit (attribute) | mcg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | Has presentation strength denominator unit (attribute) | Actuation (unit of presentation) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | Has manufactured dose form | Conventional release pressurized suspension for inhalation (dose form) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | Is a | Product manufactured as pulmonary dose form (product) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | Has presentation strength numerator value | 25 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | Has precise active ingredient | Salmeterol xinafoate | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | Is a | Fluticasone and salmeterol only product in pulmonary dose form | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | Has precise active ingredient | Fluticasone propionate | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | Has basis of strength substance (attribute) | Salmeterol (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | Has basis of strength substance (attribute) | Fluticasone propionate | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) | Has precise active ingredient | Salmeterol xinafoate | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets